McKesson and CD&R near $5B-plus deal to buy infusion services provider, FT reports

McKesson and private equity firm CD&R are near a deal worth more than $5 billion to buy an infusion services provider, the Financial Times reports. The deal is not yet confirmed.

Detected & updated continuously · Source: Nebula